TargEDys Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
TargEDys General Information
Description
Developer of microbe mechanism designed to control the metabolic disease by modulating the appetite through intervention. The company's mechanism of appetite regulation involves bacterial, hormonal mimetic, proteins that are found naturally in the gut microbiome which moderate the appetite of overweight people and restore the appetite of elderly, cachexia, or anorexic people, enabling people to regulate their eating behavior.
Contact Information
Website
www.targedys.com(Operating Subsidiary)
Corporate Office
- Zone d'activités Nativelle - Bat 4bis
- 1 Chemin de Saulxier
- 91160 Longjumeau
- France
Corporate Office
- Zone d'activités Nativelle - Bat 4bis
- 1 Chemin de Saulxier
- 91160 Longjumeau
- France
TargEDys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 19-May-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Later Stage VC | 12-Jul-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 11-Apr-2017 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2017 | $1.37M | $253K | Completed | Generating Revenue | |
| 1. Angel (individual) | 24-Jun-2015 | $253K | $253K | Completed | Generating Revenue |
TargEDys Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| P Shares | ||||||||
| P Shares | ||||||||
| Ordinary | 4,524 | $10.414674 | $52.07 | $52.07 | 1x | $52.07 | 5.88% |
TargEDys Comparisons
Industry
Financing
Details
TargEDys Competitors (16)
One of TargEDys’s 16 competitors is Rivus Pharmaceuticals, a Venture Capital-Backed company based in Charlottesville, VA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rivus Pharmaceuticals | Venture Capital-Backed | Charlottesville, VA | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| Vertero Therapeutics | Venture Capital-Backed | Woburn, MA | ||||
| Xenikos | Venture Capital-Backed | Nijmegen, Netherlands | ||||
| Vaiomer | Accelerator/Incubator Backed | Toulouse, France |
TargEDys Patents
TargEDys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4176890-A1 | Oxytocin-mimetic compositions and uses thereof | Inactive | 03-Nov-2021 | ||
| EP-4426325-A1 | Oxytocin-mimetic compositions and uses thereof | Inactive | 03-Nov-2021 | ||
| US-20250352589-A1 | Oxytocin-mimetic compositions and uses thereof | Pending | 03-Nov-2021 | ||
| WO-2023078603-A1 | Oxytocin-mimetic compositions and uses thereof | Inactive | 03-Nov-2021 | ||
| WO-2023079036-A1 | Probiotic composition comprising a lactobacillus salivarius strain, a lactobacillus camelliae strain and a bifidobacterium ruminantium strain | Inactive | 03-Nov-2021 | A61K35/747 |
TargEDys Signals
TargEDys Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Empower AI | PE-Backed Company | Minority | ||
| NCI Gestion | PE/Buyout | Minority | ||
| Normandie Incubation | Accelerator/Incubator | |||
| Onxy Developpement | Corporation | Minority |
TargEDys FAQs
-
When was TargEDys founded?
TargEDys was founded in 2011.
-
Where is TargEDys headquartered?
TargEDys is headquartered in Longjumeau, France.
-
What is the size of TargEDys?
TargEDys has 13 total employees.
-
What industry is TargEDys in?
TargEDys’s primary industry is Drug Discovery.
-
Is TargEDys a private or public company?
TargEDys is a Private company.
-
What is TargEDys’s current revenue?
The current revenue for TargEDys is .
-
How much funding has TargEDys raised over time?
TargEDys has raised $14.7M.
-
Who are TargEDys’s investors?
Bpifrance, Empower AI, NCI Gestion, Normandie Incubation, and Onxy Developpement are 5 of 8 investors who have invested in TargEDys.
-
Who are TargEDys’s competitors?
Rivus Pharmaceuticals, Enterome, Vertero Therapeutics, Xenikos, and Vaiomer are some of the 16 competitors of TargEDys.
-
When was TargEDys acquired?
TargEDys was acquired on 19-May-2023.
-
Who acquired TargEDys?
TargEDys was acquired by Biocodex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process